肝细胞癌发病危险因素Logistic回归分析*

doi:10.3969/j.issn.1672-5069.2021.06.040

Abstract

Zhao Pengfei, Zu Hongmei, Xin Xiaoen, et al. Logistic regression analysis of risk factors in patients with hepatocellular carcinoma[J]. Journal of Practical Hepatology, 2021, 24(6): 927-929.

[1] Xu W, Xu H, Yang H, et al. Continuous Pringle maneuver does not affect outcomes of patients with hepatocellular carcinoma after curative resection. Asia Pac J Clin Oncol, 2017, 13(5): e321-e330.
[2] Wu C, Li M, Meng H, et al. Analysis of status and countermeasures of cancer incidence and mortality in China. Sci China Life Sci, 2019, 62(5): 640-647.
[3] Xu X F, Xing H, Han J, et al. Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from china. JAMA Surg, 2019, 154(3): 209-217.
[4] Yang J D, Hainaut P, Gores G J, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol, 2019, 16(10): 589-604.
[5] 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版). 中华肝脏病杂志, 2020, 2(28):356-360.
[6] Akinyemiju T, Abera S, Ahmed M, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015. JAMA Oncol, 2017, 3(12): 1683-1691.
[7] Fattovich G, Stroffolini T, Zagni I, et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology, 2004, 127(5 Suppl 1): S35-50.
[8] Dundar H Z, Aksoy F, Aksoy S A, et al. Overexpression of miR-21 is associated with recurrence in patients with hepatitis B virus-mediated hepatocellular carcinoma undergoing liver transplantation. Transplant Proc, 2019, 51(4): 1157-1161.
[9] Ringelhan M, O'connor T, Protzer U, et al. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets. J Pathol, 2015, 235(2): 355-67.
[10] Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet, 2018, 391(10127): 1301-1314.
[11] 中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版). 实用肝脏病杂志, 2020, 1(23).
[12] Song C, Zhu J, Ge Z, et al. Spontaneous seroclearance of hepatitis B surface antigen and risk of hepatocellular carcinoma. Clin Gastroenterol Hepatol, 2019, 17(6): 1204-1206.

[1]	Han Chengmei, Han Yongfeng, Wang Chunhua. Risk factors for acute kidney injury in patients with hepatitis B-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(6): 883-886.
[2]	Zhou Yan, Li Guoping, Deng Jun, et al. Efficacy of thymosin alpha 1 in maintained treatment of patients with primary liver cancer after radiofrequency ablation [J]. Journal of Practical Hepatology, 2021, 24(6): 907-910.
[3]	Zhou Zheng, Liu Wei. Contrast-enhanced ultrasound features of hepatic hemangioma, hepatocellular carcinoma and hepatic angiomyolipoma [J]. Journal of Practical Hepatology, 2021, 24(6): 911-914.
[4]	Peng Guangming, Ge Shang, Jin Guiyin. Image quality of adaptive statistical iterative reconstruction under low tube voltage of CT scan in diagnosis of patients with primary liver cancer [J]. Journal of Practical Hepatology, 2021, 24(5): 737-740.
[5]	Yu Lei, Sun Chao, Zhang Manxu. Regulation of intestinal floras and their metabolism functions by ganoderma lucidum plysaceharide in mice with HepG2 cell-induced implanted cancer [J]. Journal of Practical Hepatology, 2021, 24(4): 476-479.
[6]	Yang Yanqiu, Cheng Hao, Feng Min. Evaluation of significant liver fibrosis in patients with chronic hepatitis B by ultrasonic elastography and serological indexes [J]. Journal of Practical Hepatology, 2021, 24(4): 480-483.
[7]	Chen Wei, Wei Tao, Yang Lan, et al. Expression of NLRP3 inflammasome in cancerous tissues of patients with primary liver cancer [J]. Journal of Practical Hepatology, 2021, 24(4): 544-547.
[8]	Liu Yongchang, Zhao Diantang, Sun Qifeng, et al. Application of indocyanine green fluorescence navigationand three-dimensional visualization in laparoscopic precision surgery for patients with primary liver cancer [J]. Journal of Practical Hepatology, 2021, 24(4): 561-564.
[9]	Gao Jinlong, Wang Haifeng, Li Na, et al. Target delineation accuracy of tumors for radiotherapy based on MR-T2 image in patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2021, 24(4): 565-568.
[10]	Wang Qunxian, Wang Yunchuan, Chen Youying. Effect of sevoflurane inhalation at different times during anesthesia in patients with primary liver cancer undergoing partial hepatectomy [J]. Journal of Practical Hepatology, 2021, 24(4): 597-599.
[11]	An Xiquan, Li Yan, Menggen Caicike. Clinical observation of tenofovir and sorafenib in the treatment of patients with hepatitis B associated advanced primary liver cancer [J]. Journal of Practical Hepatology, 2021, 24(4): 600-602.
[12]	Luo Weixin, Liu Chaoqun, Xu Leibo, et al. Effects of exosomes derived from rat liver cancer cells with different lung metastasis potentials on the transcriptome of macrophages [J]. Journal of Practical Hepatology, 2021, 24(3): 312-318.
[13]	Chen Shaohua, Wu Zhe, Wei Zhihong, et al. Serum oncogene and tumor suppressor gene levels in patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2021, 24(2): 244-247.
[14]	Mo Juan, Yan Wen, Xu Shaoqiang. Short-term and long-termsurvivals of patients with huge primary liver cancer after associated liver partition and portal vein ligation for staged hepatectomy [J]. Journal of Practical Hepatology, 2021, 24(2): 252-255.
[15]	Zhao Chuang, Liang Chao, Dong Baojian, et al. Analgesia of dexmedetomidine and morphine in patients with primary liver cancer undergoing transcatheter hepatic arterial chemoembolization [J]. Journal of Practical Hepatology, 2021, 24(2): 260-263.

Logistic regression analysis of risk factors in patients with hepatocellular carcinoma

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments